The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Dextromethorphan HBr. and Guaifenesin
Dextromethorphan HBr. and Guaifenesin · DEXTROMETHORPHAN HYDROBROMIDE 20 mg/10mL; GUAIFENESIN 200 mg/10mL · Solution · Oral · Rising Pharma Holdings, Inc.
NDC 57237-0313-18 · 80 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE / 10 mL in 1 CUP, UNIT-DOSE · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$216.27
Reported to Texas DSHS · 2025 annual filing · Rising Pharma Holdings, Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicaid spend (2024)
$1,475
36 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for dextromethorphan hbr, guaifenesin (other) in the next 90 days
sole-source market · price up 2% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- M012.85
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Dextromethorphan HBr. and Guaifenesin (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Everpharm LLC | DEXTROMETHORPHAN HYDROBROMIDE 10 mg/5mL; GUAIFENESIN 100 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Everpharm LLC | DEXTROMETHORPHAN HYDROBROMIDE 20 mg/10mL; GUAIFENESIN 200 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | DEXTROMETHORPHAN HYDROBROMIDE 10 mg/5mL; GUAIFENESIN 100 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | DEXTROMETHORPHAN HYDROBROMIDE 20 mg/10mL; GUAIFENESIN 200 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Dextromethorphan HBr. and Guaifenesin — NDC 57237-0313-18," retrieved September 3, 2026, https://drugdashboards.com/drug/57237031318.
Free to cite with attribution — see how the data is put together.